levodopa has been researched along with clorgyline in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (37.93) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 1 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Holzbauer, M; Youdim, MB | 1 |
| Knoll, J | 1 |
| Green, AR; Mitchell, BD; Tordoff, AF; Youdim, MB | 1 |
| Delini-Stula, A; Maître, L; Waldmeier, PC | 1 |
| Borisenko, SA; Männistö, PT; Törnwall, M; Tuomainen, P; Tuominen, RK | 1 |
| Männistö, PT; Törnwall, M | 2 |
| Cohen, G | 1 |
| Fukuda, H; Ono, H; Tanabe, M | 1 |
| Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
| Angers, M; Nguyen, TB | 1 |
| Yahr, MD | 1 |
| Carlson, GM; Gianutsos, G; Godfrey, JG | 1 |
| Youdim, MB | 1 |
| Cabbat, FS; Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Callingham, BA; Lyles, GA | 1 |
| Bankiewicz, KS; Finberg, JP; Goldstein, DS; Kopin, IJ; Wang, J | 1 |
| Matsuda, K; Miyake, T; Miyata, Y; Nishihara, S; Sakuma, M; Ui-Tei, K | 1 |
| Abercrombie, ED; Wachtel, SR | 1 |
| Chan, P; DeLanney, LE; Di Monte, DA; Irwin, I; Jakowec, MW; Langston, JW; Royland, JE | 1 |
| Brannan, T; Martínez-Tica, J; Prikhojan, A; Yahr, MD | 1 |
| Evert, BO; Klockgether, T; Kovar, KA; Rundfeldt, C; Schulz, JB; Seyfried, J; Wüllner, U | 1 |
| Campbell, JM; Davies, RW; Favor, G; Gilmore, DP; Growney, CA; Kennedy, AK; Payne, AP; Russell, D; Stone, TW | 1 |
| Archer, T; Fredriksson, A; Palomo, T | 1 |
| Casas, M; Pérez, V; Prat, G; Rubi, A; Unzeta, M | 1 |
| Francescutti-Verbeem, DM; Kuhn, DM; Thomas, DM | 2 |
| Finberg, JP; Loboda, Y; Rabey, MJ; Sader-Mazbar, O | 1 |
3 review(s) available for levodopa and clorgyline
| Article | Year |
|---|---|
Are there MAO inhibitors specific for dopamine metabolism?
Topics: Animals; Binding Sites; Brain; Clorgyline; Dopamine; Drug Synergism; Humans; In Vitro Techniques; Levodopa; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenethylamines | 1977 |
On the dual nature of monoamine oxidase.
Topics: Animals; Antidepressive Agents; Binding Sites; Brain; Catecholamines; Clorgyline; Dose-Response Relationship, Drug; Humans; Levodopa; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nictitating Membrane; Norepinephrine; Parkinson Disease; Phenethylamines; Propylamines; Protein Binding; Serotonin; Structure-Activity Relationship; Tyramine | 1978 |
R-(-)-deprenyl and parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Benserazide; Clorgyline; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Parkinson Disease; Phenethylamines; Pyridines; Selegiline; Stereoisomerism | 1987 |
26 other study(ies) available for levodopa and clorgyline
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Clorgyline; Deamination; Dopamine; Drug Interactions; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Rats; Serotonin; Time Factors; Tranylcypromine; Tryptophan | 1977 |
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Clorgyline; Corpus Striatum; Deamination; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Normetanephrine; Phenethylamines; Rats; Reserpine; Serotonin; Tyramine | 1976 |
Effect of nitecapone and clorgyline, given intracerebro-ventricularly on L-dopa metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Carbidopa; Catechols; Cerebral Ventricles; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Hypothalamus; Injections, Intraventricular; Levodopa; Male; Pentanones; Prolactin; Rats; Rats, Wistar; Thyrotropin | 1992 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
Monoamine oxidase and oxidative stress at dopaminergic synapses.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Glutathione; Glutathione Reductase; Haloperidol; In Vitro Techniques; Levodopa; Male; Mice; Monoamine Oxidase; Oxidation-Reduction; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stress, Physiological; Substantia Nigra; Synapses; Synaptosomes | 1990 |
Spinal alpha 1- and alpha 2-adrenoceptors mediate facilitation and inhibition of spinal motor transmission, respectively.
Topics: Animals; Clonidine; Clorgyline; Levodopa; Male; Motor Neurons; Piperoxan; Prazosin; Premedication; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Reflex, Monosynaptic; Spinal Cord; Synaptic Transmission | 1990 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Topics: Animals; Brain; Catecholamines; Clorgyline; Corpus Striatum; Dopamine; Hypothalamus; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Rats; Rats, Inbred Strains; Selegiline | 1987 |
Drug-induced changes in motor activity after selective MAO inhibition.
Topics: Amphetamine; Animals; Brain; Clorgyline; Harmaline; Isoenzymes; Levodopa; Male; Mice; Monoamine Oxidase; Motor Activity; Pargyline; Phenethylamines; Propylamines | 1983 |
In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B.
Topics: Animals; Brain; Clorgyline; Levodopa; Male; Monoamine Oxidase; Norepinephrine; Rats; Rats, Inbred Strains | 1983 |
Potentiation by deprenil of 1-dopa induced circling in nigral-lesioned rats.
Topics: Animals; Clorgyline; Dopamine; Humans; Hydroxydopamines; Isomerism; Levodopa; Male; Oxidopamine; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Stereotyped Behavior; Substantia Nigra | 1981 |
In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.
Topics: Amine Oxidase (Copper-Containing); Animals; Benserazide; Cardiovascular System; Clorgyline; Drug Resistance; Hydrazines; In Vitro Techniques; Kinetics; Levodopa; Male; Monoamine Oxidase; Oxidoreductases Acting on CH-NH Group Donors; Propylamines; Rats; Rats, Inbred Strains | 1982 |
Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Indans; Levodopa; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline; Substantia Nigra | 1995 |
Chemical analysis of neurotransmitter candidates in clonal cell lines from Drosophila central nervous system. I. ACh and L-dopa.
Topics: Acetylcholine; Animals; Biogenic Monoamines; Catecholamines; Central Nervous System; Chromatography, High Pressure Liquid; Clone Cells; Clorgyline; Drosophila; Electrochemistry; Levodopa; Neurotransmitter Agents | 1994 |
Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.
Topics: Amidines; Amphetamine; Animals; Behavior, Animal; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Clorgyline; Drug Interactions; Drug Synergism; Levodopa; Male; Methylation; Nitriles; Nitrophenols; Pyridones; Rats; Rats, Wistar; Tolcapone | 1993 |
L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Levodopa; Male; Monoamine Oxidase Inhibitors; Nerve Endings; Oxidopamine; Picolinic Acids; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Female; Isoenzymes; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Saimiri; Selegiline; Substantia Nigra | 1996 |
In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline | 1995 |
Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells.
Topics: Aminopyridines; Analgesics; Animals; Antidepressive Agents; Carbamates; Cell Death; Clorgyline; Culture Media; Cystine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Phenylenediamines; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate | 2000 |
Pharmacological analysis of extracellular dopamine and metabolites in the striatum of conscious as/agu rats, mutants with locomotor disorder.
Topics: Amphetamine; Animals; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Extracellular Space; Levodopa; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Movement Disorders; Nomifensine; Potassium; Reference Values | 2000 |
Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Phenelzine; Phenethylamines; Selegiline; Thiazoles; Tryptamines | 2000 |
The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats.
Topics: Adrenergic Agents; Animals; Clorgyline; Corpus Striatum; Dopamine Agents; Dopamine Uptake Inhibitors; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidopamine; Parkinsonian Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Selegiline; Substantia Nigra | 2000 |
Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; Animals; Central Nervous System Stimulants; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Female; Humans; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Neurotoxins; Presynaptic Terminals; Reserpine | 2008 |
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
Topics: Animals; Clorgyline; Cytosol; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Levodopa; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Neurons; Neurotoxicity Syndromes; Nucleus Accumbens; Plant Lectins; Reserpine; Ribosome Inactivating Proteins; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Basal Ganglia; Clorgyline; Dopamine; Dopamine Agents; Dopaminergic Neurons; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Indans; Levodopa; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Organic Anion Transporters, Sodium-Independent; Oxidopamine; Rats; Rats, Sprague-Dawley; Serotonergic Neurons | 2013 |